We are approaching research and development differently to create smarter T cells designed to overcome tumor microenvironment challenges.

 

At Tmunity, we are implementing novel science into the clinic to find faster pathways to patients.

Our pipeline includes investigational next-generation therapies for a range of cancers including prostate, myeloma, melanoma and synovial sarcoma. We invite you to explore our pipeline*.

The table illustrates our discovery programs and opportunities as of January 2020

* Full pipeline not shown   ** NYCE- New York CRISPR-edited   ***In collaboration with UCSF   **** In collaboration with CHOP